Antidiabetic effects of interleukin 1.
Interleukin 1 (IL-1), a cytokine released mainly by activated macrophages-monocytes, affects glucose homeostasis and may mediate some of the metabolic derangements observed during certain inflammatory and infectious processes. In this report, it is shown that IL-1 acts as a hypoglycemic agent not on...
Enregistré dans:
| Publié dans: | Proc Natl Acad Sci U S A |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
National Academy of Sciences
1989
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC297747/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2668949/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.86.15.5943 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|